BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

...fever Dengue virus capsid protein Preclinical studies suggest a vaccine based on the fusion of dengue virus envelope protein E (DENV_gp1)...
BioCentury | Dec 22, 2017
Product R&D

Dengvaxia’s warning

...of the Health Sciences, Bethesda, Md. Targets prM - Dengue virus precursor-membrane protein DENV_gp1 - Dengue virus envelope protein E...
BioCentury | Sep 26, 2017
Distillery Therapeutics

Infectious disease

...half-life of the anti-DENV_gp1 mAb and testing it in non-human primate models of Zika. TARGET/MARKER/PATHWAY: Dengue virus envelope protein E (DENV_gp1)...
...Medicine, St. Louis, Mo. email: diamond@borcim.wustl.edu Claire Quang Imperial College London Washington University School of Medicine in St. Louis Dengue virus envelope protein E (DENV_gp1)...
BioCentury | Feb 28, 2017
Distillery Techniques

Biomarkers

...hemorrhagic fever or dengue shock syndrome had higher plasma levels of non-neutralizing IgG antibodies against dengue virus envelope protein E (DENV_gp1)...
...doi:10.1126/science.aai8128 CONTACT: Jeffrey V. Ravetch, The Rockefeller University, New York, N.Y. email: ravetch@rockefeller.edu Mary Romeo The Rockefeller University Dengue virus envelope protein E (DENV_gp1) Fc...
BioCentury | Jun 2, 2016
Translation in Brief

Double duty in dengue

...the pre-infection activity could be due to an extracellular target, and homed in on the dengue virus envelope protein E (DENV_gp1)...
BioCentury | May 26, 2016
Distillery Therapeutics

Therapeutics: BCR-ABL tyrosine kinase (BCR-ABL); dengue virus envelope protein E (DENV_gp1)

...AG markets Gleevac to treat multiple types of cancer. TARGET/MARKER/PATHWAY: BCR-ABL tyrosine kinase (BCR-ABL) ; dengue virus envelope protein E (DENV_gp1)...
BioCentury | Aug 27, 2015
Distillery Techniques

Techniques: Structural analysis of a human mAb-dengue virus envelope protein E (DENV_gp1) complex for vaccine design

Drug platforms TECHNOLOGY: Structural analyses dengue virus envelope protein E (DENV_gp1) National University of Singapore Vanderbilt University BC Staff...
BioCentury | Aug 13, 2015
Distillery Therapeutics

Therapeutics: Dengue virus envelope protein E (DENV_gp1)

...for other viral diseases including Ebola and influenza. (See "Antibodies with Muscle", page 14) TARGET/MARKER/PATHWAY: Dengue virus envelope protein E (DENV_gp1)...
BioCentury | Aug 6, 2015
Product R&D

Impede a fever

...Institute of Technology (MIT), Cambridge, Mass. Visterra Inc., Cambridge, Mass. Targets and Compounds DENV_gp1 - Dengue virus envelope protein E...
...with the Vaxfectin adjuvant Phase I Altravax Inc. Dengue virus vaccine Chimeric tetravalent vaccine against dengue virus envelope protein E (DENV_gp1)...
BioCentury | Jul 23, 2015
Distillery Therapeutics

Therapeutics: Dengue virus envelope protein E (DENV_gp1)

...the dengue virus domain III of DENV_gp1, in preclinical development to treat dengue fever. TARGET/MARKER/PATHWAY: Dengue virus envelope protein E (DENV_gp1)...
Items per page:
1 - 10 of 16